Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
8,093,378
-
Shares change
-
-1,018,587
-
Total reported value, excl. options
-
$499,022,609
-
Value change
-
-$70,945,248
-
Put/Call ratio
-
72%
-
Number of buys
-
76
-
Number of sells
-
84
-
Price
-
$61.67
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2019
As of 31 Dec 2019 ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) had 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,093,378 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., MANGROVE PARTNERS, STATE STREET CORP, INVESTMENT COUNSELORS OF MARYLAND LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and FIRST MANHATTAN CO.
This table shows 204 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.